top of page
Drug Pricing & Affordability


PDAB Chicanery: How Drug Affordability Boards Are Undermining Public Engagement
PDABs say they’re helping patients. In reality, they’re muzzling public input and playing politics with life-saving medications.

Travis Roppolo
Mar 306 min read


HIV Long-Acting Injectables Face Policy Hurdles After CROI 2025
One shot a year could transform HIV care. But unless we fix access and policy, these breakthroughs won’t reach those who need them most.

Travis Roppolo
Mar 166 min read


Patients Still at Risk: The State of Copay Accumulator Adjustment Policies in 2025
Copay accumulator policies make patients pay twice. It's 2025, and insurers are still profiting while patients go broke.

Travis Roppolo
Mar 97 min read


Healthcare in the Lame Duck
Congress faces urgent healthcare decisions before 2025—telehealth, CHC funding, and physician payments hang in the balance during lame duck.

Travis Roppolo
Dec 8, 202410 min read
bottom of page



